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Objective:  We sought to identify whether elevated PaO2 itself can directly cause
hyperglycemia in newborns and to document any additional effects of cardiopul-
monary bypass on this response.
Methods:  Piglets were exposed to either normoxia (88 ± 6 mm Hg) or hyperoxia
(470 ± 28 mm Hg) in the following studies. Anesthetized 3-day-old neonatal pigs
were either ventilated for 2 hours of normoxia (n = 5) or hyperoxia (n = 5) or placed
on normothermic, normoxic cardiopulmonary bypass (n = 6) and then randomly
assigned to either undergo a 2-hour normoxic period or a 1-hour hyperoxic episode,
followed by a return to normoxia for an additional hour. Blood glucose levels were
measured in all animals.
Results:  No significant changes were observed in blood glucose levels in neonatal
pigs that underwent 2 hours of normoxic ventilation (5.0 ± 0.6 mmol/L) or car-
diopulmonary bypass (6.6 ± 1.6 mmol/L). However, the ventilatory model showed
a significant and sustained (P < .001) hyperglycemic response after both 1 hour (8.6
± 1.0 mmol/L) and 2 hours (9.8 ± 1.6 mmol/L) of hyperoxia. In the cardiopul-
monary bypass model, exposure to 1 hour of hyperoxia elicited a significant (P <
.05) hyperglycemic response (10.3 ± 1.2 mmol/L), followed by a return to normal
blood glucose levels (6.6 ± 1.6 mmol/L) with a return to normoxia. This hyperox-
ia-mediated hyperglycemic response was confirmed when data examined from chil-
dren undergoing cardiopulmonary bypass for primary repair of their congenital
defects also identified a significant positive correlation (r = 0.72, P = .02) between
oxygen levels and blood glucose levels measured before and at the end of car-
diopulmonary bypass.
Conclusions:  Hyperoxia triggers a hyperglycemic response in both ventilatory and
bypass models. Cardiopulmonary bypass does not exacerbate this response, as
shown by the similar levels of hyperglycemia sustained for the duration of the
hyperoxic exposure in both experimental models. Therefore, not only may hyper-
oxia play a crucial role in the hyperglycemic response seen during neonatal car-
diopulmonary bypass, but its effect on glucose homeostasis should be considered
whenever children are exposed to hyperoxia.
Children undergoing surgical repair for congenital heart disease areoften placed on cardiopulmonary bypass (CPB) during cardiacoperations.1-3 The use of deep hypothermia in combination withCPB was thought to provide optimal conditions for cardiac surgicalrepair4-7 but can result in hyperglycemia.8 Persistent hyperglycemiain children has been shown to cause osmotic diuresis, dehydration,
glycosylation of proteins, and an increased incidence of cerebral hemorrhage.9,10
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Hypothermia-induced reductions in insulin secretion by
inhibition of the pancreatic secretory process has been
thought to be the cause of this hyperglycemic response that is
commonly seen in children placed on CPB for cardiac
repair.5,8,11-13 However, other evidence in the literature has
indicated that hypothermia may not be the primary factor.8 In
fact, hyperglycemic responses in adults undergoing cardiac
repair have been documented, even under normothermic con-
ditions.14 Whether the hyperglycemic response seen in chil-
dren undergoing cardiac repair persists under normothermic
conditions has not been addressed.
Other factors in CPB, such as hypokalemia and hypocal-
cemia, have also been thought to contribute to the hyper-
glycemic response through the inhibition of insulin
release.5,15,16 However, studies in adults have demonstrated
that neither of these factors is consistently implicated.5,8,17-19
Other studies with adult patients have also speculated that
hyperglycemia during CPB is caused by exogenous admin-
istration of glucose, either in intravenous or cardioplegic
solutions,20,21 whereas others have pointed to the impor-
tance of enhanced reabsorption of filtered glucose in the
development of hyperglycemia during CPB.22 Therefore,
the primary factor responsible for the hyperglycemic
response seen in patients undergoing cardiac operations
remains controversial, and moreover, the primary factor that
causes hyperglycemia in children remains unresolved.
In the majority of neonatal CPB cases, high oxygen lev-
els (hyperoxia) have been used23; however, the effect of
hyperoxia on neonatal glucose homeostasis remains essen-
tially unexplored.
Although multivariate analysis may be used in patients to
statistically determine the contribution of hyperoxia to
hyperglycemia, the physiologic effect of hyperoxia on glu-
cose metabolism in the presence of confounding variables
cannot be ignored. For example, the presence of heart dis-
ease or varying degrees of cyanosis may itself affect glucose
handling and the hyperglycemic response. The models used
in this study provide the unique opportunity to examine the
pure effect of oxygen on neonatal blood glucose levels in a
controlled experimental setting with a ventilatory model in
the absence of CPB because CPB is also associated with the
release of several neurohumoral factors.24,25 Whether these
factors can contribute to the hyperglycemic response is
unknown. Therefore, a CPB model was used to determine
whether CPB exaggerates the potential hyperoxia-mediated
hyperglycemia and whether this response was rapidly
reversible with a return to normoxia. 
Methods
Neonatal Yorkshire pigs were chosen as the animal model in which
to study the effects of hyperoxia because the cardiac and pulmonary
systems of newborn human subjects and pigs have many structural
and functional similarities.26,27 Yorkshire pigs (3 days old, 1.5-2.5
kg) were anesthetized with an intraperitoneal injection of sodium
pentobarbital (65 mg/kg; MTC Pharmaceuticals, Cambridge,
Ontario, Canada), intubated, and mechanically ventilated to normal
blood gases (PaO2, 88 ± 6 mm Hg; PaCO2, 38 ± 5 mm Hg) with med-
ical air. Normothermia (37.9°C ± 0.2°C) was maintained in each
piglet. A catheter was inserted into the right carotid artery and
advanced to the aortic arch to monitor arterial blood pressure
through a pressure transducer (Cobe Laboratories, Lakewood,
Colo), which was connected to a physiologic recorder (Biopac
Systems Inc, Goleta, Calif). This catheter was also used for sam-
pling of blood gases and glucose measurements.
Arterial blood gases (PaO2 and PaCO2) and acid-base status (pH
and bicarbonate [HCO3–]) were monitored at regular intervals with
an ABL30 Acid-Base Analyzer (Radiometer, Copenhagen,
Denmark), and appropriate ventilatory adjustments ensured that
PaO2 and PaCO2 remained at the desired levels.
Blood glucose measurements were made with the Accu-Chek
Advantage Blood Glucose Monitoring System (Boerhinger
Mannheim, Laval, Quebec, Canada). Measurements of both PaO2
and blood glucose levels were made at 0-, 1-, and 2-hour intervals
(Figure 1). Plasma insulin measurements were made with a
porcine insulin enzyme-linked immunosorbent assay (ALPCO
Diagnostics, Windham, NH) from samples taken both at the 0- and
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Figure 1. Surgical protocols for CPB and the ventilatory models.
Hatched and open areas represent episodes of hyperoxia and nor-
moxia, respectively.
TABLE 1. Measurements of blood glucose and PaO2 at base-
line and 2 hours of normoxia
Baseline 2 Hours 
Protocol Parameter value of normoxia
Ventilation Glucose (mmol/L) 5.0 ± 1.0 5.3 ± 0.3
PaO2 (mm Hg) 86 ± 9 84 ± 7
CPB Glucose (mmol/L) 5.6 ± 1.6 6.6 ± 1.6
PaO2 (mm Hg) 84 ± 20 96 ± 14
CPB, Cardiopulmonary bypass.
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2-hour intervals from representative normoxic (n = 4) and hyper-
oxic (n = 3) piglets in the ventilatory model.
In those piglets placed on normoxic, normothermic CPB with a
Sarns 9000 perfusion system (3M/Sarns, Inc, Ann Arbor, Mich), sys-
temic heparinization (heparin sulfate, 400 IU/kg; Leo Pharma Inc,
Ajax, Ontario, Canada) was instituted after sternotomy was per-
formed. Appropriate perfusion adjustments maintained mean arteri-
al blood pressure (61 ± 1 mm Hg), and blood gases were maintained
with a Minimax membrane oxygenator (Medtronic, Inc, Anaheim,
Calif). Heparin was administered to maintain an activated clotting
time of greater than 400 seconds, sodium bicarbonate was adminis-
tered to maintain pH (7.40 ± 0.02), and sodium pentobarbital was
administered to ensure a surgical plane of anesthesia.
Experimental Protocol
A 2-hour ventilatory model was developed in which animals were
randomly allocated to normoxic control (n = 5) or hyperoxic (n =
5; 1 hour: 441 ± 36 mm Hg, 2 hours: 509 ± 42 mm Hg) study
groups (Figure 1). So that we could determine whether CPB exag-
gerated the potential hyperoxia-mediated hyperglycemia response,
an additional 6 neonatal pigs were placed on normothermic, nor-
moxic CPB. Three of these piglets underwent a 1-hour hyperoxic
(304 ± 145 mm Hg) episode and were then returned to normoxia
for an additional hour, and the remaining 3 piglets underwent a 2-
hour exposure to normoxia (Figure 1).
All experimental procedures and protocols used in this investi-
gation were reviewed and approved by the University of Toronto
Animal Care and Use Committee and are in accordance with the
“Guide for the Care and Use of Laboratory Animals” prepared by
the Institute of Laboratory Animal Resources, National Research
Council, and published by the National Academy Press, revised
1996, and Canadian Council on Animal Care guidelines.
Statistical Analysis
One-way analysis of variance with the Tukey post hoc test was used
to analyze differences in blood glucose levels in the animals placed
on CPB. Repeated-measures analysis of variance with the Duncan
multiple-range post hoc test was used to identify differences
between normoxic and hyperoxic groups across time in the ventila-
tory model. Differences in plasma insulin levels measured from ven-
tilated animals were compared by means of paired t-test analysis. All
data are expressed as means ± standard deviation.
Results
Ventilatory Model
No significant changes were observed in blood glucose lev-
els in neonatal pigs that underwent 2 hours of normoxic
ventilation (Table 1). In contrast, after initial normoxia, ini-
Figure 2. Neonatal oxygen levels (A) and blood glucose levels (B)
during 2 hours of hyperoxic ventilation. Post hoc analysis yielded
the following statistically significant differences: †P < .001 versus
normoxia. ANOVA, Analysis of variance.
Figure 3. Plasma insulin levels measured in piglets at baseline
(open bar) and at the end of either 2 hours of normoxic (filled bar)
or hyperoxic (cross-hatched bar) ventilation. Paired t-test
analysis yielded the following statistically significant differ-
ences: ‡P < .01 versus baseline.
A
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tiation of hyperoxia was confirmed by increases in PaO2 (P
< .001) throughout the 2-hour period (Figure 2, A). Blood
glucose levels increased significantly by 40% during the
first hour and were further increased by 12% in the second
hour of hyperoxia (Figure 2, B). No significant changes
were observed in plasma insulin levels in piglets that under-
went 2 hours of normoxic ventilation (Figure 3). However,
in contrast, plasma insulin levels were significantly
increased (P < .01) by 3-fold at the end of the 2-hour hyper-
oxic ventilatory period (Figure 3).
CPB Model
No significant changes were observed in blood glucose levels
in neonatal pigs that underwent 2 hours of normoxic CPB
(Table 1). Figure 4, A, shows that with the induction of hyper-
oxia, PaO2 levels were appropriately significantly elevated
during 1 hour (P < .05) of hyperoxia and successfully
returned to normoxia for another hour. Blood glucose levels
(Figure 4, B) of neonatal pigs that underwent normothermic
hyperoxic CPB began within the normal physiologic range
during the initial normoxic exposure. In response to 1 hour of
hyperoxia, blood glucose levels showed a significant 46%
increase (P < .05). Once normoxia was re-established, blood
glucose was then shown to quickly return to normal (P < .05).
These data illustrated that hyperoxia-induced hyper-
glycemia occurred in both ventilatory and CPB normother-
mic models and returned to normal when normoxia was
restored, thereby confirming the effect of hyperoxia alone
on neonatal blood glucose levels. Similar levels of hyper-
glycemia sustained for the duration of the hyperoxic expo-
sure in both experimental models also suggest that CPB
does not exacerbate the hyperglycemic response.
Discussion
Hyperglycemia is frequently observed in children during
CPB. Although the underlying cause of this response during
CPB has been historically ascribed to a decrease in insulin
secretion mediated by such factors as hypothermia,
hypocalcemia, and hypokalemia,5,15,16 none of these factors
has been consistently implicated.5-8,17-19 The inconsistency
in the outcome of these studies may be partly explained by
the fact that a majority of these studies do not evaluate
hyperglycemia as an independent variable without the pres-
ence of confounding variables, such as congenital heart
defects, cyanosis, and preoperative medications. Moreover,
the potential contribution of hyperoxia commonly used in
neonatal CPB to the hyperglycemic response remains essen-
tially unexplored.
Because the newborn pig model closely resembles the
structure, function, and cardiovascular physiology of a new-
born child,26,27 the models used in this study provided an
opportunity to identify the potential relationship between
hyperglycemia and PaO2 in the absence of confounding vari-
ables normally found in pediatric patients. The ventilatory
model was first used to clearly identify the pure effect of
oxygen on neonatal blood glucose levels in the absence of
CPB by using a 2-hour protocol of severe hyperoxia and
showed a significant hyperoxia-induced hyperglycemic
response. Once this relationship was established, a CPB
model with clinically relevant levels of hyperoxia was used
to determine whether CPB exaggerated the hyperoxia-medi-
ated hyperglycemic response and whether this response was
rapidly reversible in the presence of normoxia. This study
clearly demonstrates that similar hyperglycemic levels
Cardiopulmonary Support and Physiology Bandali, Belanger, Wittnich
Figure 4. Neonatal oxygen levels (A) and blood glucose levels (B)
during 2 hours of CPB. Post hoc analysis yielded the following sta-
tistically significant differences: *P < .05 versus normoxia.
ANOVA, Analysis of variance.
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resulted by using 2 different models and hyperoxic levels,
therefore suggesting that CPB does not potentiate the hyper-
glycemic response. Furthermore, neonatal blood glucose
levels quickly returned to normal in the CPB model once
normoxia was re-established. Therefore, not only may
hyperoxia play a crucial role in the hyperglycemic response
seen in neonatal CPB, but its effect on glucose homeostasis
should be considered whenever children are exposed to
hyperoxia.
This was borne out when 5 children between 11 and 18
months of age who underwent routine CPB for primary
repair of their congenital defects at the Hospital for Sick
Children (Toronto, Canada) were studied. They had normal
preoperative blood glucose levels, and during the operation,
they demonstrated a significant and strong positive correla-
tion (r = 0.72, P = .02) between their absolute oxygen and
blood glucose levels (Figure 5), confirming that hyperoxia
is indeed an important contributor to the hyperglycemic
response seen in children who are placed on CPB during
primary repair for congenital heart defects. It should be
noted that the hyperoxic levels used in our CPB piglet
model in this study were similar to the levels seen in this
clinical work, and because of some variability in the actual
degree of hyperoxia attained, the CPB model also had a
strong positive correlation between oxygen and glucose lev-
els (r = 0.84, P = .03). The 2-hour time course chosen for
both our experimental models was based on similar time
courses commonly seen in children undergoing CPB for pri-
mary cardiac repair.
Although this work illustrates that hyperoxia is an impor-
tant and major contributor to the hyperglycemia seen in
neonatal CPB, the potential contribution of hypothermia,
electrolyte differences, inotropic agents, and exogenous glu-
cose (depending on rate and concentration of administra-
tion) cannot be ruled out, despite never being consistently
implicated in past studies. These and other factors, such as
the presence of metabolic alkalosis and variable rates of glu-
cose uptake, as seen in a recent study,28 may potentially
exacerbate or blunt the hyperoxia-induced hyperglycemic
response seen during neonatal CPB.
The mechanisms that underlie the hyperoxia-induced
hyperglycemic response may involve alterations in enzymes
or other glucose regulators. Studies examining the effects of
extreme hyperbaric hyperoxia have shown inhibitory effects
on many metabolic enzymes that are important in both gly-
colysis and aerobic metabolism.29 In addition, some studies
have implicated reductions in insulin secretion as a potential
contributor to the hyperglycemia seen in children placed on
CPB for cardiac repair.5,8,11-13 However, in contrast to these
studies, insulin levels measured in piglets exposed to hyper-
oxia for 2 hours showed a significant 3-fold elevation. This
may implicate insulin resistance as one possible mechanism
for the hyperoxia-mediated hyperglycemic response. In
addition, it is interesting to note that the development of
hyperglycemia in both the ventilatory and CPB model
occurred within 15 minutes of the hyperoxia exposure. In
light of this rapidly induced hyperglycemia, the potential
role of hormonal changes, such as insulin levels, may be
particularly important in elucidating the mechanisms that
underlie this response.
The development of hyperglycemia in children has been
shown to cause osmotic diuresis, dehydration, and the gly-
cosylation of proteins.9 The most serious potential effect of
hyperglycemia has been emphasized by studies that demon-
strate increased mortality.9,10 Specifically, a certain cohort
of low-birth-weight newborn infants receiving parenteral
glucose at birth had persistent hyperglycemia during the
first 24 hours and were at high risk of having a cerebral
hemorrhage.9,10 Thus, depending on the magnitude and
duration of the hyperglycemic response to hyperoxia, these
detrimental effects could also be of potential concern in
children undergoing CPB.
In addition to the hyperglycemic response triggered by
the use of hyperoxia during CPB, hyperoxia itself may
detrimentally affect neonates undergoing primary cardiac
repair. The potential detrimental effects of hyperoxia have
been alluded to in the literature.23,30 The original rationale
for the use of hyperoxia during cardiac operations was to
overcome the hypothermia-induced leftward shift of the
oxygen-hemoglobin dissociation curve and thus ensure ade-
quate oxygen delivery. Although some degree of hyperoxia
may be essential to ensure adequate oxygenation under
hypothermic conditions, the rationale for the use of hyper-
oxia under normothermic conditions is unclear.23
Furthermore, a recent study reports that although hyperoxia
provides a myocardial energy-sparing effect during early
Figure 5. Significant correlation (P = .02, r = 0.72) between oxygen
and blood glucose levels in children undergoing standard CPB in
the neonatal period for primary repair of tetralogy of Fallot.
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ischemia, including minimized reductions in myocardial
adenosine triphosphate and glycogen content, it also
increased the incidence of ventricular fibrillation, which
negated this beneficial metabolic effect.23
Work by Ihnken and colleagues30 has also shown that the
use of hyperoxia in immature hypoxemic piglet hearts dur-
ing CPB resulted in increased susceptibility to oxygen-
mediated damage after reintroduction of molecular oxygen.
This unintended reoxygenation injury causes lipid peroxi-
dation, enzyme release, endothelial and intracellular lesions
leading to membrane damage, and reduced myocardial per-
formance. Furthermore, the authors went on to show that
reductions in high oxygen levels in the bypass prime and in
blood cardioplegic solution to normoxia can reduce the
damaging changes associated with hyperoxia and improve
contractility in previously hypoxic pig hearts.
The current study shows that hyperoxia itself can elicit a
hyperglycemic response as seen in neonatal pigs in both a
ventilatory and CPB model. This hyperglycemic response is
abolished with the reduction of oxygen levels to normoxia.
Moreover, clinical data in children undergoing cardiac oper-
ations show a strong positive correlation between PaO2 and
glucose levels, confirming the animal findings. The rela-
tionship between PaO2 and glucose elucidated in these chil-
dren appear dose-dependent until severe hyperoxic levels
are reached. Therefore, in addition to the increased inci-
dence of ventricular fibrillation and oxygen-mediated dam-
age that has been shown in animal studies to accompany
unintended reoxygenation injury, the use of hyperoxia in
children during CPB does appear to contribute to alterations
in blood glucose homeostasis. This may potentially con-
tribute to postoperative complications seen in certain chil-
dren undergoing cardiac operations. Therefore, for neonatal
myocardial protection to be optimized, consideration may
need to be given to adjustments in the optimal levels of oxy-
gen used.
We acknowledge the contributions of Cathy Carlyle, Shona M.
Torrance, and W. Jack Wallen. 
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